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Background
Tuberculosis is a common opportunistic infection and
HIV patients with latent TB infection are at risk of reac-
tivation and those with recently acquired infection are at
high risk of progressive primary TB. Approximately
1000 people in the western pacific region die from the
disease every day. The threat of increasing HIV rates
fuelling the TB epidemic has become an important mas-
sive challenge in Fiji to the control of TB at all levels.
Hence this study was to evaluate the rate of TB co
infection among HIV patients in Fiji.
Methods
This study involved the retrospective descriptive analysis
of the data available in the PJ Twomey Hospital, Suva,
Fiji. All registered cases of HIV and HIV-TB has been
included in the study.
Results
By 2010, Fiji has 191 registered cases of tuberculosis and
393 HIV positive. The % of TB patients with known
HIV status is 100 because of the recent Fiji HIV/TB sur-
veillance policy which recommends that HIV testing is
mandatory in all newly diagnosed cases of TB for all
health care settings. Fiji has reported 2% of new TB
patients every year which are also HIV positive and the
mortality rate of HIV/TB patients is very high (80%).
Conclusion
The HIV positive co-infected with TB have developed
active TB than patients who are HIV negative. Hence
the TB/HIV co-infected were started TB therapy prior
to ARVs. TB treatment reduces the burden of HIV in
people living with TB.
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